High Risk Melanoma clinical trials

Explore recruiting high risk melanoma clinical trials.

Recruiting high risk melanoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

High Risk Melanoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 2 clinical trial on neoadjuvant pembrolizumab in patients diagnosed with high-risk melanoma without clinical evidence of metastatic dissemination.

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Adjuvant nivolumab treatment in stage II high-risk melanoma – A randomized, controlled, phase III trial with biomarker-based risk stratification (NivoMela)

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 Trial of Fianlimab (anti-LAG-3) and Cemiplimab versus Pembrolizumab in the Adjuvant Setting in Patients with Completely Resected High-risk Melanoma

Czechia, Belgium, France, Romania, Ireland, Italy +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

High Risk Melanoma trials by city

High Risk Melanoma in Toronto High Risk Melanoma in Vancouver High Risk Melanoma in Montreal High Risk Melanoma in Calgary High Risk Melanoma in Edmonton High Risk Melanoma in Ottawa High Risk Melanoma in Winnipeg High Risk Melanoma in Quebec City High Risk Melanoma in Hamilton High Risk Melanoma in Kitchener High Risk Melanoma in London High Risk Melanoma in Halifax High Risk Melanoma in New York High Risk Melanoma in Los Angeles High Risk Melanoma in Chicago High Risk Melanoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease